Galmed Pharmaceuticals (GLMD) Stock Chart & Stock Price History $2.09 +0.16 (+8.01%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$2.10 +0.01 (+0.48%) As of 07/14/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Galmed Pharmaceuticals Stock Price Performance The Galmed Pharmaceuticals (GLMD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 42.44%, with a year-to-date return of -34.48%. In the past month, the stock has increased 30.63%, reflecting recent market activity. As of the latest close, Galmed Pharmaceuticals traded at $2.09 with a market cap of $3.45 million and volume of 447,281 shares. Five years ago, the stock traded at a split-adjusted price of $849.60, representing a 99.75% decrease over that period. At the time, it had a market cap of $120.12 million and a volume of 369 shares. Receive GLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.96%1 Month Performance+30.63%3 Month Performance+48.23%Year-To-Date Performance-34.48%1 Year Performance-42.44%5 Year Performance-99.75% GLMD Stock Chart for Tuesday, July, 15, 2025 GLMD Chart by TradingView Galmed Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/14/2025$1.93$2.09+8.29%$2.13$1.93447,281 shs$3.45 million07/11/2025$2.03$1.93-4.93%$2.05$1.87317,224 shs$3.18 million07/10/2025$2.18$2.03-6.88%$2.16$2.03258,571 shs$3.35 million07/09/2025$2.09$2.18+4.31%$2.22$2.05750,149 shs$3.61 million07/08/2025$1.83$2.09+14.21%$2.09$1.82547,773 shs$3.45 million07/07/2025$1.81$1.83+1.39%$1.92$1.74433,272 shs$3.02 million07/04/2025$1.81$1.81$1.85$1.79110,435 shs$2.98 million07/03/2025$1.81$1.81-0.28%$1.85$1.79110,435 shs$2.98 million07/02/2025$1.78$1.81+1.69%$1.83$1.76142,487 shs$2.99 million07/01/2025$1.84$1.78-3.26%$1.85$1.74230,352 shs$2.94 million Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/30/2025$1.81$1.84+1.66%$1.90$1.79238,443 shs$3.04 million06/27/2025$1.79$1.81+1.12%$1.87$1.75112,210 shs$2.99 million06/26/2025$1.81$1.79-1.10%$1.83$1.75233,381 shs$2.95 million06/25/2025$1.85$1.81-2.16%$1.94$1.80372,368 shs$2.99 million06/24/2025$1.75$1.85+5.71%$1.85$1.75412,988 shs$3.05 million06/23/2025$1.87$1.75-6.42%$1.88$1.63700,702 shs$2.89 million06/20/2025$1.78$1.87+5.06%$1.90$1.81934,112 shs$3.09 million06/19/2025$1.78$1.78$1.83$1.66592,315 shs$2.94 million06/18/2025$1.68$1.78+6.27%$1.83$1.66592,315 shs$2.94 million06/17/2025$1.73$1.68-3.18%$1.74$1.66294,815 shs$2.77 million06/16/2025$1.60$1.73+8.12%$1.79$1.62835,984 shs$2.86 million Related Companies LPTX Stock Chart IMCC Stock Chart SNPX Stock Chart BTAI Stock Chart NERV Stock Chart PHIO Stock Chart BGXX Stock Chart EQ Stock Chart ABP Stock Chart BCLI Stock Chart Receive GLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLMD) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
